Hydroxychloroquine, an anti-malaria drug President Donald Trump pushed for weeks and admitted he was taking to try to prevent contracting coronavirus offers no benefit in COVID-19 patients and in fact is linked to a “significantly higher risk of death.” The Washington Post reports on a just-released study published in the renowned medical journal the Lancet, which examined records of 96,000 hospitalized coronavirus patients.